# EDGAR Filing Document

**Accession Number:** 0000886982
**File Stem:** 0001193125-25-307861
**Filing Date:** 2025-12
**Character Count:** 36136
**Document Hash:** c22c3ffd5d26dc7492b065bffd9b9e22
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-307861.hdr.sgml**: 20251204

**ACCESSION NUMBER**: 0001193125-25-307861

**CONFORMED SUBMISSION TYPE**: FWP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251204

**DATE AS OF CHANGE**: 20251204

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GOLDMAN SACHS GROUP INC
- **CENTRAL INDEX KEY:** 0000886982
- **STANDARD INDUSTRIAL CLASSIFICATION:** SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 134019460
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-284538
- **FILM NUMBER:** 251548883

**BUSINESS ADDRESS:**
- **STREET 1:** 200 WEST STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10282
- **BUSINESS PHONE:** 212-902-1000

**MAIL ADDRESS:**
- **STREET 1:** 200 WEST STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10282

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GOLDMAN SACHS GROUP INC/
- **DATE OF NAME CHANGE:** 20010104
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GOLDMAN SACHS GROUP INC
- **CENTRAL INDEX KEY:** 0000886982
- **STANDARD INDUSTRIAL CLASSIFICATION:** SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 134019460
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP

**BUSINESS ADDRESS:**
- **STREET 1:** 200 WEST STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10282
- **BUSINESS PHONE:** 212-902-1000

**MAIL ADDRESS:**
- **STREET 1:** 200 WEST STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10282

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GOLDMAN SACHS GROUP INC/
- **DATE OF NAME CHANGE:** 20010104

Free Writing Prospectus pursuant to Rule 433 dated December 4, 2025 / Registration Statement No. 333-284538

STRUCTURED INVESTMENTS

Opportunities in U.S. Equities

---

| | |
|:---|:---|
| &nbsp;&nbsp;![img16681181_0.jpg](img16681181_0.jpg) | &nbsp;&nbsp;**GS Finance Corp.** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Jump Securities with Auto-Callable Feature Based on the Performance of the Worst-Performing of the State Street**<sup>®</sup> **Energy Select Sector SPDR**<sup>®</sup> **ETF, the State Street**<sup>®</sup> **Utilities Select Sector SPDR**<sup>®</sup> **ETF and the State Street**<sup>®</sup> **SPDR**<sup>®</sup> **S&P**<sup>®</sup> **Biotech ETF due December 17, 2031**<br>**Principal At Risk Securities** | &nbsp;&nbsp;**Jump Securities with Auto-Callable Feature Based on the Performance of the Worst-Performing of the State Street**<sup>®</sup> **Energy Select Sector SPDR**<sup>®</sup> **ETF, the State Street**<sup>®</sup> **Utilities Select Sector SPDR**<sup>®</sup> **ETF and the State Street**<sup>®</sup> **SPDR**<sup>®</sup> **S&P**<sup>®</sup> **Biotech ETF due December 17, 2031**<br>**Principal At Risk Securities** | &nbsp;&nbsp;**Jump Securities with Auto-Callable Feature Based on the Performance of the Worst-Performing of the State Street**<sup>®</sup> **Energy Select Sector SPDR**<sup>®</sup> **ETF, the State Street**<sup>®</sup> **Utilities Select Sector SPDR**<sup>®</sup> **ETF and the State Street**<sup>®</sup> **SPDR**<sup>®</sup> **S&P**<sup>®</sup> **Biotech ETF due December 17, 2031**<br>**Principal At Risk Securities** | &nbsp;&nbsp;**Jump Securities with Auto-Callable Feature Based on the Performance of the Worst-Performing of the State Street**<sup>®</sup> **Energy Select Sector SPDR**<sup>®</sup> **ETF, the State Street**<sup>®</sup> **Utilities Select Sector SPDR**<sup>®</sup> **ETF and the State Street**<sup>®</sup> **SPDR**<sup>®</sup> **S&P**<sup>®</sup> **Biotech ETF due December 17, 2031**<br>**Principal At Risk Securities** | &nbsp;&nbsp;**Jump Securities with Auto-Callable Feature Based on the Performance of the Worst-Performing of the State Street**<sup>®</sup> **Energy Select Sector SPDR**<sup>®</sup> **ETF, the State Street**<sup>®</sup> **Utilities Select Sector SPDR**<sup>®</sup> **ETF and the State Street**<sup>®</sup> **SPDR**<sup>®</sup> **S&P**<sup>®</sup> **Biotech ETF due December 17, 2031**<br>**Principal At Risk Securities** | &nbsp;&nbsp;**Jump Securities with Auto-Callable Feature Based on the Performance of the Worst-Performing of the State Street**<sup>®</sup> **Energy Select Sector SPDR**<sup>®</sup> **ETF, the State Street**<sup>®</sup> **Utilities Select Sector SPDR**<sup>®</sup> **ETF and the State Street**<sup>®</sup> **SPDR**<sup>®</sup> **S&P**<sup>®</sup> **Biotech ETF due December 17, 2031**<br>**Principal At Risk Securities** | &nbsp;&nbsp;**Jump Securities with Auto-Callable Feature Based on the Performance of the Worst-Performing of the State Street**<sup>®</sup> **Energy Select Sector SPDR**<sup>®</sup> **ETF, the State Street**<sup>®</sup> **Utilities Select Sector SPDR**<sup>®</sup> **ETF and the State Street**<sup>®</sup> **SPDR**<sup>®</sup> **S&P**<sup>®</sup> **Biotech ETF due December 17, 2031**<br>**Principal At Risk Securities** |
| **The securities are unsecured notes issued by GS Finance Corp. and guaranteed by The Goldman Sachs Group, Inc.**  | **The securities are unsecured notes issued by GS Finance Corp. and guaranteed by The Goldman Sachs Group, Inc.**  | **<u>Call observation dates</u>** | **<u>Call payment dates</u>** | **<u>Call payment dates</u>** | **<u>Call payment dates</u>** | **<u>Call premium amount</u>** |
| **The securities are unsecured notes issued by GS Finance Corp. and guaranteed by The Goldman Sachs Group, Inc.**  | **The securities are unsecured notes issued by GS Finance Corp. and guaranteed by The Goldman Sachs Group, Inc.**  | December 21, 2026 | December 21, 2026 | December 24, 2026 | December 24, 2026 | at least 13% |
| **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | March 12, 2027 | March 12, 2027 | March 17, 2027 | March 17, 2027 | at least 16.25% |
| **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | June 14, 2027 | June 14, 2027 | June 17, 2027 | June 17, 2027 | at least 19.5% |
| **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | September 13, 2027 | September 13, 2027 | September 16, 2027 | September 16, 2027 | at least 22.75% |
| **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | **You should read the accompanying preliminary pricing supplement dated December 4, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.** | December 13, 2027 | December 13, 2027 | December 16, 2027 | December 16, 2027 | at least 26% |
| ***KEY TERMS*** | ***KEY TERMS*** | March 13, 2028 | March 13, 2028 | March 16, 2028 | March 16, 2028 | at least 29.25% |
| **Company (Issuer) / Guarantor:**  | GS Finance Corp. / The Goldman Sachs Group, Inc. | June 12, 2028 | June 12, 2028 | June 15, 2028 | June 15, 2028 | at least 32.5% |
| **Company (Issuer) / Guarantor:**  | GS Finance Corp. / The Goldman Sachs Group, Inc. | September 12, 2028 | September 12, 2028 | September 15, 2028 | September 15, 2028 | at least 35.75% |
| **Underlying ETFs (each individually, an underlying ETF):** | the State Street<sup>®</sup> Energy Select Sector SPDR<sup>®</sup> ETF (current Bloomberg symbol: "XLE UP Equity"), the State Street<sup>®</sup> Utilities Select Sector SPDR<sup>®</sup> ETF (current Bloomberg symbol: "XLU UP Equity") and the State Street<sup>®</sup> SPDR<sup>®</sup> S&P<sup>®</sup> Biotech ETF (current Bloomberg symbol: "XBI UP Equity") | December 12, 2028 | December 12, 2028 | December 15, 2028 | December 15, 2028 | at least 39% |
| **Underlying ETFs (each individually, an underlying ETF):** | the State Street<sup>®</sup> Energy Select Sector SPDR<sup>®</sup> ETF (current Bloomberg symbol: "XLE UP Equity"), the State Street<sup>®</sup> Utilities Select Sector SPDR<sup>®</sup> ETF (current Bloomberg symbol: "XLU UP Equity") and the State Street<sup>®</sup> SPDR<sup>®</sup> S&P<sup>®</sup> Biotech ETF (current Bloomberg symbol: "XBI UP Equity") | March 12, 2029 | March 12, 2029 | March 15, 2029 | March 15, 2029 | at least 42.25% |
| **Underlying ETFs (each individually, an underlying ETF):** | the State Street<sup>®</sup> Energy Select Sector SPDR<sup>®</sup> ETF (current Bloomberg symbol: "XLE UP Equity"), the State Street<sup>®</sup> Utilities Select Sector SPDR<sup>®</sup> ETF (current Bloomberg symbol: "XLU UP Equity") and the State Street<sup>®</sup> SPDR<sup>®</sup> S&P<sup>®</sup> Biotech ETF (current Bloomberg symbol: "XBI UP Equity") | June 12, 2029 | June 12, 2029 | June 15, 2029 | June 15, 2029 | at least 45.5% |
| **Indices (each individually, an index)** | with respect to an underlying ETF, the index tracked by such underlying ETF | September 12, 2029 | September 12, 2029 | September 17, 2029 | September 17, 2029 | at least 48.75% |
| **Indices (each individually, an index)** | with respect to an underlying ETF, the index tracked by such underlying ETF | December 12, 2029 | December 12, 2029 | December 17, 2029 | December 17, 2029 | at least 52% |
| **Pricing date:** | expected to price on or about December 12, 2025 | March 12, 2030 | March 12, 2030 | March 15, 2030 | March 15, 2030 | at least 55.25% |
| **Original issue date:** | expected to be December 17, 2025 | June 12, 2030 | June 12, 2030 | June 17, 2030 | June 17, 2030 | at least 58.5% |
| **Call observation dates:** | as set forth under "Call observation dates" below  | September 12, 2030 | September 12, 2030 | September 17, 2030 | September 17, 2030 | at least 61.75% |
| **Call payment dates:** | as set forth under "Call payment dates" below | December 12, 2030 | December 12, 2030 | December 17, 2030 | December 17, 2030 | at least 65% |
| **Valuation date:** | expected to be December 12, 2031 | March 12, 2031 | March 12, 2031 | March 17, 2031 | March 17, 2031 | at least 68.25% |
| **Stated maturity date:** | expected to be December 17, 2031 | June 12, 2031 | June 12, 2031 | June 17, 2031 | June 17, 2031 | at least 71.5% |
| **Automatic call feature:** | if, as measured on any call observation date, the closing price of each underlying ETF is greater than or equal to its call threshold price, your securities will be automatically called and you will receive for each $1,000 principal amount an amount in cash equal to the sum of (i) $1,000 plus (ii) the product of $1,000 times the call premium amount applicable to the corresponding call observation date. No payments will be made after the call payment date. | September 12, 2031 | September 12, 2031 | September 17, 2031 | September 17, 2031 | at least 74.75% |
| **Automatic call feature:** | if, as measured on any call observation date, the closing price of each underlying ETF is greater than or equal to its call threshold price, your securities will be automatically called and you will receive for each $1,000 principal amount an amount in cash equal to the sum of (i) $1,000 plus (ii) the product of $1,000 times the call premium amount applicable to the corresponding call observation date. No payments will be made after the call payment date. |  |  |  |  |  |
| **Automatic call feature:** | if, as measured on any call observation date, the closing price of each underlying ETF is greater than or equal to its call threshold price, your securities will be automatically called and you will receive for each $1,000 principal amount an amount in cash equal to the sum of (i) $1,000 plus (ii) the product of $1,000 times the call premium amount applicable to the corresponding call observation date. No payments will be made after the call payment date. |  |  |  |  |  |
| **Automatic call feature:** | if, as measured on any call observation date, the closing price of each underlying ETF is greater than or equal to its call threshold price, your securities will be automatically called and you will receive for each $1,000 principal amount an amount in cash equal to the sum of (i) $1,000 plus (ii) the product of $1,000 times the call premium amount applicable to the corresponding call observation date. No payments will be made after the call payment date. | ***Hypothetical Payment Amount At Maturity\**** | ***Hypothetical Payment Amount At Maturity\**** | ***Hypothetical Payment Amount At Maturity\**** | ***Hypothetical Payment Amount At Maturity\**** | ***Hypothetical Payment Amount At Maturity\**** |
| **Payment at maturity (for each $1,000 stated principal amount of your securities):** | &nbsp;&nbsp;&nbsp;&nbsp;•if the final ETF price of <u>each</u> underlying ETF is greater than or equal to its downside threshold price, the sum of (i) $1,000 *plus* (ii) the *product* of (a) $1,000 *times* (b) the maturity date premium amount; or<br>•if the final ETF price of <u>any</u> underlying ETF is less than its downside threshold price, $1,000 × the worst performing ETF performance factor  | **The Securities Have <u>Not</u> Been Automatically Called** | **The Securities Have <u>Not</u> Been Automatically Called** | **The Securities Have <u>Not</u> Been Automatically Called** | **The Securities Have <u>Not</u> Been Automatically Called** | **The Securities Have <u>Not</u> Been Automatically Called** |
| **Payment at maturity (for each $1,000 stated principal amount of your securities):** | &nbsp;&nbsp;&nbsp;&nbsp;•if the final ETF price of <u>each</u> underlying ETF is greater than or equal to its downside threshold price, the sum of (i) $1,000 *plus* (ii) the *product* of (a) $1,000 *times* (b) the maturity date premium amount; or<br>•if the final ETF price of <u>any</u> underlying ETF is less than its downside threshold price, $1,000 × the worst performing ETF performance factor  | **Hypothetical Final Share Price of the Worst Performing Underlying Stock** <br>**(as Percentage of Initial Share Price)** | **Hypothetical Final Share Price of the Worst Performing Underlying Stock** <br>**(as Percentage of Initial Share Price)** | **Hypothetical Final Share Price of the Worst Performing Underlying Stock** <br>**(as Percentage of Initial Share Price)** | **Hypothetical Payment at Maturity** <br>**(as Percentage of Stated Principal Amount)** | **Hypothetical Payment at Maturity** <br>**(as Percentage of Stated Principal Amount)** |
| **Payment at maturity (for each $1,000 stated principal amount of your securities):** | &nbsp;&nbsp;&nbsp;&nbsp;•if the final ETF price of <u>each</u> underlying ETF is greater than or equal to its downside threshold price, the sum of (i) $1,000 *plus* (ii) the *product* of (a) $1,000 *times* (b) the maturity date premium amount; or<br>•if the final ETF price of <u>any</u> underlying ETF is less than its downside threshold price, $1,000 × the worst performing ETF performance factor  | 200.000% | 200.000% | 200.000% | 178.000% | 178.000% |
| **Initial ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the pricing date | 175.000% | 175.000% | 175.000% | 178.000% | 178.000% |
| **Initial ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the pricing date | 150.000% | 150.000% | 150.000% | 178.000% | 178.000% |
| **Initial ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the pricing date | 125.000% | 125.000% | 125.000% | 178.000% | 178.000% |
| **Final ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the valuation date | **100.000%** | **100.000%** | **100.000%** | **178.000%** | **178.000%** |
| **Final ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the valuation date | 95.000% | 95.000% | 95.000% | 178.000% | 178.000% |
| **Final ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the valuation date | 92.000% | 92.000% | 92.000% | 178.000% | 178.000% |
| **Final ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the valuation date | **90.000%** | **90.000%** | **90.000%** | **178.000%** | **178.000%** |
| **Final ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the valuation date | 89.999% | 89.999% | 89.999% | 89.999% | 89.999% |
| **Final ETF price:** | with respect to each underlying ETF, the closing price of such underlying ETF on the valuation date | 75.000% | 75.000% | 75.000% | 75.000% | 75.000% |
| **Call threshold price:** | with respect to each underlying ETF, 90.00% of such underlying ETF's initial ETF price | 50.000% | 50.000% | 50.000% | 50.000% | 50.000% |
| **Call threshold price:** | with respect to each underlying ETF, 90.00% of such underlying ETF's initial ETF price | 30.000% | 30.000% | 30.000% | 30.000% | 30.000% |
| **Downside threshold price:** | with respect to each underlying ETF, 90.00% of such underlying ETF's initial ETF price | 25.000% | 25.000% | 25.000% | 25.000% | 25.000% |
| **Downside threshold price:** | with respect to each underlying ETF, 90.00% of such underlying ETF's initial ETF price | **0.000%** | **0.000%** | **0.000%** | **0.000%** | **0.000%** |
| **Call premium amount (set on the pricing date):** | with respect to any call observation date, the applicable call premium amount set forth under "Call premium amount" below |  |  |  |  |  |
| **Call premium amount (set on the pricing date):** | with respect to any call observation date, the applicable call premium amount set forth under "Call premium amount" below | \*assumes a maturity date premium amount of 78.00% | \*assumes a maturity date premium amount of 78.00% | \*assumes a maturity date premium amount of 78.00% | \*assumes a maturity date premium amount of 78.00% | \*assumes a maturity date premium amount of 78.00% |
| **Maturity date premium amount (set on the pricing date):** | at least 78.00% |  |  |  |  |  |
| **ETF performance factor:** | with respect to each underlying ETF, the final ETF price / the initial ETF price |  |  |  |  |  |
| **Worst performing underlying ETF:** | the underlying ETF with the lowest ETF performance factor |  |  |  |  |  |
| **Worst performing ETF performance factor:** | the ETF performance factor of the worst performing underlying ETF |  |  |  |  |  |
| **CUSIP / ISIN:** | 40058WFU5 / US40058WFU53 |  |  |  |  |  |
| **Estimated value range:** | $855 to $915 (which is less than the original issue price; see the accompanying preliminary pricing supplement) |  |  |  |  |  |

---

*This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in the securities without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the underlying ETFs (including historical closing prices of the underlying ETFs), the terms of the securities and certain risks.*

------

***About Your Securities***<br>

The amount that you will be paid on your securities is based on the performance of the worst performing of the State Street<sup>®</sup> Energy Select Sector SPDR<sup>®</sup> ETF, the State Street<sup>®</sup> Utilities Select Sector SPDR<sup>®</sup> ETF and the State Street<sup>®</sup> SPDR<sup>®</sup> S&P<sup>®</sup> Biotech ETF. The securities may be automatically called on any call observation date.

**The return on your securities is linked to the performance of each underlying ETF, and in each case not to that of the index on which such underlying ETF is based.**

Your securities will be automatically called if the closing price of <u>each</u> underlying ETF on any call observation date is *greater than* or *equal to* its call threshold price, resulting in a payment on the applicable call payment date equal to (i) the principal amount of your securities *plus* (ii) such principal amount *times* the call premium amount applicable to such call observation date. No payments will be made after the call payment date.

At maturity, if not previously called, you may lose a significant portion or all of your investment in the securities. You will not participate in any appreciation of the underlying ETFs.

The securities are for investors who seek a return of between at least 13.00% and at least 78.00%, depending on if and when the securities are automatically called, in exchange for the risk of losing all or a significant portion of the principal amount of their securities if the securities remain outstanding to maturity.

**GS Finance Corp. and The Goldman Sachs Group, Inc. have filed a registration statement (including a prospectus, as supplemented by the prospectus supplement, general terms supplement no. 17,744 and preliminary pricing supplement listed below) with the Securities and Exchange Commission (SEC) for the offering to which this communication relates. Before you invest, you should read the prospectus, prospectus supplement, general terms supplement no. 17,744 and preliminary pricing supplement and any other documents relating to this offering that GS Finance Corp. and The Goldman Sachs Group, Inc. have filed with the SEC for more complete information about us and this offering. You may get these documents without cost by visiting EDGAR on the SEC web site at sec.gov. Alternatively, we will arrange to send you the prospectus, prospectus supplement, general terms supplement no. 17,744 and preliminary pricing supplement if you so request by calling (212) 357-4612.**

The securities are notes that are part of the Medium-Term Notes, Series F program of GS Finance Corp. and are fully and unconditionally guaranteed by The Goldman Sachs Group, Inc. This document should be read in conjunction with the following:

• [<u>Preliminary pricing supplement dated December 4, 2025</u>](https://www.sec.gov/Archives/edgar/data/886982/000119312525307794/wonsr006_prelim.htm)

• [<u>General terms supplement no. 17,744 dated October 20, 2025</u>](https://www.sec.gov/Archives/edgar/data/886982/000119312525243221/gts_no._17744_2025_shelf.htm)

• [<u>Prospectus supplement dated February 14, 2025</u>](https://www.sec.gov/Archives/edgar/data/886982/000119312525027380/d891153d424b2.htm)

• [<u>Prospectus dated February 14, 2025</u>](https://www.sec.gov/Archives/edgar/data/886982/000119312525027379/d860775d424b2.htm)

*This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in the securities without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the underlying ETFs (including historical closing prices of the underlying ETFs), the terms of the securities and certain risks.*

------

&nbsp;&nbsp;***RISK FACTORS***<br>

An investment in the securities is subject to risks. Many of the risks are described in the accompanying preliminary pricing supplement, accompanying general terms supplement no. 17,744, accompanying prospectus supplement and accompanying prospectus. Below we have provided a list of certain risk factors discussed in such documents. In addition to the below, you should read in full "Risk Factors" in the accompanying preliminary pricing supplement, "Additional Risk Factors Specific to the Notes" in the accompanying general terms supplement no. 17,744, as well as the risks and considerations described in the accompanying prospectus supplement and accompanying prospectus. Your securities are a riskier investment than ordinary debt securities. Also, your securities are not equivalent to investing directly in the underlying ETF stocks, i.e., with respect to an underlying ETF to which your securities are linked, the stocks comprising such underlying ETF. You should carefully consider whether the offered securities are appropriate given your particular circumstances.

**The following risk factors are discussed in greater detail in the accompanying preliminary pricing supplement:**

**<u>Risks Related to Structure, Valuation and Secondary Market Sales</u>**

▪You May Lose Your Entire Investment in the Securities

▪The Return on Your Securities May Change Significantly Despite Only a Small Incremental Change in the Price of the Worst Performing Underlying ETF

▪The Securities Are Subject to the Credit Risk of the Issuer and the Guarantor

▪The Amount You Will Receive on a Call Payment Date or on the Stated Maturity Date, as the Case May Be, Will Be Capped

▪Your Securities Are Subject to Automatic Redemption

▪The Amount You Will Receive on a Call Payment Date or on the Stated Maturity Date Is Not Linked to the Closing Prices of the Underlying ETFs at Any Time Other Than on the Applicable Call Observation Date or the Valuation Date, as the Case May Be

▪The Payment at Maturity Will Be Based Solely on the Worst Performing Underlying ETF

▪Because the Securities Are Linked to the Performance of the Worst Performing Underlying ETF, You Have a Greater Risk of Sustaining a Significant Loss on Your Investment Than If the Securities Were Linked to Just One Underlying ETF

▪You are Exposed to the Market Risk of Each Underlying ETF

▪The Estimated Value of Your Securities At the Time the Terms of Your Securities Are Set On the Pricing Date (as Determined By Reference to Pricing Models Used By GS&Co.) Is Less Than the Original Issue Price Of Your Securities

▪The Market Value of Your Securities May Be Influenced By Many Unpredictable Factors

▪The Return on Your Securities Will Not Reflect Any Dividends Paid on the Underlying ETFs or the Underlying ETF Stocks

▪Investing in the Securities is Not Equivalent to Investing in the Underlying ETF; You Have No Shareholder Rights or Rights to Receive Any Shares of the Underlying ETFs or Any Underlying ETF Stocks

▪We May Sell an Additional Aggregate Stated Principal Amount of the Securities at a Different Issue Price

▪If You Purchase Your Securities at a Premium to Stated Principal Amount, the Return on Your Investment Will Be Lower Than the Return on Securities Purchased at Stated Principal Amount and the Impact of Certain Key Terms of the Securities Will be Negatively Affected

**<u>Risks Related to Conflicts of Interest</u>**

▪Other Investors May Not Have the Same Interests as You

**<u>Additional Risks Related to the Underlying ETFs</u>**

▪The Policies of the Underlying ETF's Investment Advisor For Any Underlying ETF and of the Index Publisher of the Index Tracked By Any Underlying ETF Could Affect the Amount Payable on Your Securities and Their Market Value

▪There Is No Assurance That an Active Trading Market Will Continue For the Underlying ETFs or That There Will Be Liquidity in Any Such Trading Market; Further, the Underlying ETFs Are Subject to Management Risks, Securities Lending Risks and Custody Risks

*This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in the securities without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the underlying ETFs (including historical closing prices of the underlying ETFs), the terms of the securities and certain risks.*

------

▪Each Underlying ETF and Its Index Are Different and the Performance of Each Underlying ETF May Not Correlate With the Performance of Its Index

**<u>Additional Risks Related to the State Street</u>**<sup>®</sup> **<u>Energy Select Sector SPDR</u>**<sup>®</sup> **<u>ETF</u>**

▪The State Street<sup>®</sup> Energy Select Sector SPDR<sup>®</sup> ETF Is Concentrated in the Energy Sector and Does Not Provide Diversified Exposure

▪The State Street<sup>®</sup> Energy Select Sector SPDR<sup>®</sup> ETF May Be Disproportionately Affected By the Performance of a Small Number of Stocks

**<u>Additional Risks Related to the State Street</u>**<sup>®</sup> **<u>Utilities Select Sector SPDR</u>**<sup>®</sup> **<u>ETF</u>**

▪The State Street<sup>®</sup> Utilities Select Sector SPDR<sup>®</sup> ETF Is Concentrated in the Utilities Sector and Does Not Provide Diversified Exposure

**<u>Additional Risks Related to the State Street</u>**<sup>®</sup> **<u>SPDR</u>**<sup>®</sup> **<u>S&P</u>**<sup>®</sup> **<u>Biotech ETF</u>**

▪The State Street<sup>®</sup> SPDR<sup>®</sup> S&P<sup>®</sup> Biotech ETF Is Concentrated in Biotechnology Companies and Does Not Provide Diversified Exposure

**<u>Risks Related to Tax</u>**

▪Your Securities May Be Subject to an Adverse Change in Tax Treatment in the Future

▪Non-United States Holders Should Consider the Withholding Tax Implications of Owning the Securities

▪Your Securities May Be Subject to the Constructive Ownership Rules

▪Foreign Account Tax Compliance Act (FATCA) Withholding May Apply to Payments on Your Securities, Including as a Result of the Failure of the Bank or Broker Through Which You Hold the Securities to Provide Information to Tax Authorities

**The following risk factors are discussed in greater detail in the accompanying general terms supplement no. 17,744:**

**<u>Risks Related to Structure, Valuation and Secondary Market Sales</u>**

▪If the Value of an Underlier Changes, the Market Value of Your Notes May Not Change in the Same Manner

▪Past Performance is No Guide to Future Performance

▪Your Notes May Not Have an Active Trading Market

▪The Calculation Agent Will Have the Authority to Make Determinations That Could Affect the Market Value of Your Notes, When Your Notes Mature and the Amount, If Any, Payable on Your Notes

▪The Calculation Agent Can Postpone the Determination Date, Averaging Date, Call Observation Date or Coupon Observation Date If a Market Disruption Event or Non-Trading Day Occurs or Is Continuing

▪With Respect to Notes Linked to Index Stocks or Exchange-Traded Funds, You Have Limited Anti-Dilution Protection

▪With Respect to Notes Linked to Exchange-Traded Funds, Except to the Extent GS&Co. and One or More of Our Other Affiliates Act as Authorized Participants in the Distribution of, and, at Any Time, May Hold, Shares of, the Applicable Exchange-Traded Fund to Which Your Notes Are Linked, There Is No Affiliation Between the Investment Advisor of such Exchange-Traded Fund and Us

**<u>Risks Related to Conflicts of Interest</u>**

▪Hedging Activities by Goldman Sachs or Our Distributors May Negatively Impact Investors in the Notes and Cause Our Interests and Those of Our Clients and Counterparties to be Contrary to Those of Investors in the Notes

▪Goldman Sachs' Trading and Investment Activities for its Own Account or for its Clients Could Negatively Impact Investors in the Notes

▪Goldman Sachs' Market-Making Activities Could Negatively Impact Investors in the Notes

▪You Should Expect That Goldman Sachs Personnel Will Take Research Positions, or Otherwise Make Recommendations, Provide Investment Advice or Market Color or Encourage Trading Strategies That Might Negatively Impact Investors in the Notes

*This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in the securities without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the underlying ETFs (including historical closing prices of the underlying ETFs), the terms of the securities and certain risks.*

------

▪Goldman Sachs Regularly Provides Services to, or Otherwise Has Business Relationships with, a Broad Client Base, Which May Include the Sponsors of the Underlier or Underliers or Constituent Indices, As Applicable, the Investment Advisors of the Underlier or Underliers, As Applicable, or the Issuers of the Underlier or the Underlier Stocks or Other Entities That Are Involved in the Transaction

▪The Offering of the Notes May Reduce an Existing Exposure of Goldman Sachs or Facilitate a Transaction or Position That Serves the Objectives of Goldman Sachs or Other Parties

**<u>Risks Related to Tax</u>**

▪Certain Considerations for Insurance Companies and Employee Benefit Plans

**The following risk factors are discussed in greater detail in the accompanying prospectus supplement:**

▪The Return on Indexed Notes May Be Below the Return on Similar Securities

▪The Issuer of a Security or Currency That Serves as an Index Could Take Actions That May Adversely Affect an Indexed Note

▪An Indexed Note May Be Linked to a Volatile Index, Which May Adversely Affect Your Investment

▪An Index to Which a Note Is Linked Could Be Changed or Become Unavailable

▪We May Engage in Hedging Activities that Could Adversely Affect an Indexed Note

▪Information About an Index or Indices May Not Be Indicative of Future Performance

▪We May Have Conflicts of Interest Regarding an Indexed Note

**The following risk factors are discussed in greater detail in the accompanying prospectus:**

*Risks Relating to Regulatory Resolution Strategies and Long-Term Debt Requirements*

▪The application of regulatory resolution strategies could increase the risk of loss for holders of our securities in the event of the resolution of Group Inc.

▪The application of Group Inc.'s proposed resolution strategy could result in greater losses for Group Inc.'s security holders

&nbsp;&nbsp;***TAX CONSIDERATIONS***<br>

You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption "Supplemental Discussion of U.S. Federal Income Tax Consequences" concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax advisor.

*This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in the securities without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the underlying ETFs (including historical closing prices of the underlying ETFs), the terms of the securities and certain risks.*

------